- Home
- NSSC vs BBNX Comparison
NSSC vs BBNX Comparison
Compare NSSC & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSSC
- BBNX
- Stock Information
- Founded
- NSSC 1969
- BBNX 2015
- Country
- NSSC United States
- BBNX United States
- Employees
- NSSC N/A
- BBNX N/A
- Industry
- NSSC Telecommunications Equipment
- BBNX Medical/Dental Instruments
- Sector
- NSSC Telecommunications
- BBNX Health Care
- Exchange
- NSSC Nasdaq
- BBNX Nasdaq
- Market Cap
- NSSC 899.1M
- BBNX 841.5M
- IPO Year
- NSSC N/A
- BBNX 2025
- Fundamental
- Price
- NSSC $29.80
- BBNX $14.71
- Analyst Decision
- NSSC Strong Buy
- BBNX Strong Buy
- Analyst Count
- NSSC 5
- BBNX 10
- Target Price
- NSSC $33.60
- BBNX $25.20
- AVG Volume (30 Days)
- NSSC 317.2K
- BBNX 536.5K
- Earning Date
- NSSC 08-25-2025
- BBNX 08-06-2025
- Dividend Yield
- NSSC 1.89%
- BBNX N/A
- EPS Growth
- NSSC N/A
- BBNX N/A
- EPS
- NSSC 1.22
- BBNX N/A
- Revenue
- NSSC $181,227,000.00
- BBNX $69,830,000.00
- Revenue This Year
- NSSC N/A
- BBNX $32.79
- Revenue Next Year
- NSSC $6.02
- BBNX $36.59
- P/E Ratio
- NSSC $24.28
- BBNX N/A
- Revenue Growth
- NSSC N/A
- BBNX 38911.17
- 52 Week Low
- NSSC $19.00
- BBNX $8.89
- 52 Week High
- NSSC $58.09
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- NSSC 64.38
- BBNX N/A
- Support Level
- NSSC $26.44
- BBNX N/A
- Resistance Level
- NSSC $29.17
- BBNX N/A
- Average True Range (ATR)
- NSSC 0.87
- BBNX 0.00
- MACD
- NSSC 0.01
- BBNX 0.00
- Stochastic Oscillator
- NSSC 84.17
- BBNX 0.00
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.